ATE119166T1 - An hiv relatierte peptide. - Google Patents

An hiv relatierte peptide.

Info

Publication number
ATE119166T1
ATE119166T1 AT90311056T AT90311056T ATE119166T1 AT E119166 T1 ATE119166 T1 AT E119166T1 AT 90311056 T AT90311056 T AT 90311056T AT 90311056 T AT90311056 T AT 90311056T AT E119166 T1 ATE119166 T1 AT E119166T1
Authority
AT
Austria
Prior art keywords
hiv
terminal
related peptides
peptides
fragments
Prior art date
Application number
AT90311056T
Other languages
English (en)
Inventor
Paul H Naylor
Su Sun Wang
Original Assignee
Viral Technologies Inc
Univ George Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23666609&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE119166(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Viral Technologies Inc, Univ George Washington filed Critical Viral Technologies Inc
Application granted granted Critical
Publication of ATE119166T1 publication Critical patent/ATE119166T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90311056T 1989-10-12 1990-10-09 An hiv relatierte peptide. ATE119166T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42046989A 1989-10-12 1989-10-12

Publications (1)

Publication Number Publication Date
ATE119166T1 true ATE119166T1 (de) 1995-03-15

Family

ID=23666609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90311056T ATE119166T1 (de) 1989-10-12 1990-10-09 An hiv relatierte peptide.

Country Status (17)

Country Link
EP (3) EP0620009A1 (de)
JP (1) JPH03209398A (de)
KR (1) KR910007962A (de)
CN (1) CN1052310A (de)
AT (1) ATE119166T1 (de)
AU (1) AU6393990A (de)
CA (1) CA2027455A1 (de)
DE (1) DE69017352T2 (de)
DK (1) DK0426314T3 (de)
ES (1) ES2071038T3 (de)
GB (1) GB2236754A (de)
GR (1) GR3015244T3 (de)
HU (1) HUT55035A (de)
IE (1) IE67533B1 (de)
IL (1) IL95890A0 (de)
NZ (1) NZ235538A (de)
ZA (1) ZA907944B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
US6103239A (en) * 1996-08-09 2000-08-15 Cel-Sci Corporation Modified HGP-30 heteroconjugates, compositions and methods of use
NO314588B1 (no) 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
ATE478089T1 (de) 2001-08-07 2010-09-15 Medestea Int Spa Isolierte polypeptide auf der grundlage des neutralisierenden epitops des p17-proteins vom hiv geeignet als impfstoffe und neutralisierende anti-p17-antikörper, die besagtes epitop spezifisch erkennen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6713287A (en) * 1986-01-06 1987-07-09 F. Hoffmann-La Roche & Co. Expression of htlv-iii gag-gene
ZA873215B (en) * 1986-05-19 1987-10-28 Viral Technologies Inc. Htlv-iii/lav virus related peptides,antibodies to the peptides,vaccines,passive and active immunization against aids virus and diagnostic test for the serological detection of aids virus
EP0273716B1 (de) * 1986-12-30 1993-08-11 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Synthetische Peptide, die zelluläre Immunität gegen den AIDS-Virus und dessen Proteine erzeugen
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
DK643188A (da) * 1987-11-24 1989-05-25 Smithkline Biolog Ekspression af hiv-proteiner i e.coli og s.cerevisiae
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion

Also Published As

Publication number Publication date
KR910007962A (ko) 1991-05-30
NZ235538A (en) 1992-06-25
EP0620010A1 (de) 1994-10-19
GR3015244T3 (en) 1995-06-30
JPH03209398A (ja) 1991-09-12
EP0620009A1 (de) 1994-10-19
EP0426314B1 (de) 1995-03-01
IL95890A0 (en) 1991-07-18
DE69017352D1 (de) 1995-04-06
ES2071038T3 (es) 1995-06-16
IE67533B1 (en) 1996-04-03
AU6393990A (en) 1991-04-18
ZA907944B (en) 1991-10-30
EP0426314A3 (en) 1991-07-24
EP0426314A2 (de) 1991-05-08
GB2236754A (en) 1991-04-17
DE69017352T2 (de) 1995-10-05
DK0426314T3 (da) 1995-03-27
HU906421D0 (en) 1991-04-29
HUT55035A (en) 1991-04-29
CN1052310A (zh) 1991-06-19
GB9021942D0 (en) 1990-11-21
CA2027455A1 (en) 1991-04-13
IE903604A1 (en) 1991-04-24

Similar Documents

Publication Publication Date Title
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
DE60026332D1 (de) Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
BR9500732B1 (pt) kit diagnóstico para a detecção de anticorpos contra vìrus que causam imunodeficiência.
DE68928130D1 (de) Synthetische vom HIV-GP120-env-Protein abgeleitete Peptide und ihre Anwendung
ES8801839A1 (es) Procedimiento para detectar anticuerpos a htlv-iii y diagnosticar aids, arc o estados pre-aids
FR2669338B1 (de)
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
ATE119166T1 (de) An hiv relatierte peptide.
EP0572737A3 (de) Gag-Env Fusion-Antigen aus HIV.
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
ATE202114T1 (de) Verwendung von peptiden welche eine immunantwort bewirken zur herstellung von medikamenten zur induzierung der immunsuppression.
PT87239A (pt) Process for the preparation of peptides
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
DK0811067T3 (da) Equin arteritisviruspeptider, antistoffer og deres anvendelse i en diagnostisk test
TH9844A (th) เพพไทด์ที่สัมพันธุ์ hiv
SE8705197D0 (sv) New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
HUP9900766A2 (hu) Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez
TH13136A (th) แอนติเจนของ hiv

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked